Medical Marijuana Inc Announces Major Deal to Distribute Three Beverages With New Hemp and Cannabis Extract Technology From CannaBANK Inc.

SAN DIEGO, CA–(Marketwire – May 16, 2011) – Medical Marijuana Inc is proud to announce that CannaBANK™’s patent pending CBD (Cannabidiol) extraction process will allow for direct infusion of the health and wellness benefits providing CBD’s into three new bottled water enhanced beverages. This technology will be used by Medical Marijuana Inc (PINKSHEETS: MJNA) to bottle and distribute these beverages in the world beverage marketplace. Medical Marijuana Inc is reviewing several bids for the distribution rights in Latin America as well as the United States. Bottled drinking water market alone exceeds 8.7 billion gallons (wholesale market $11.2 billion) in the USA and is close approaching the Carbonated Soft Drink market in terms of annual sales. Source: figures).

CBD-infused water will have all the advantages of traditional pure spring water plus the added health and wellness benefits of CBD. The beverages will be marketed throughout similar distribution channels as bottled drinking water at retail and grocery outlets, so as to be readily available to the general populace in the next few months.

CBD is an extract from cannabis and contains none of the psychoactive ingredients of marijuana, known as THC. CBD has been well studied by major University Medical Research Schools in the United States. One CBD benefit is to reduce DNA damage due to free radical species, anti-aging of neural, CNS, COPD, and other cellular targets. This is described in the United States Health Department Patent # 6,630,507 titled “Cannabis as Antioxidants and Neuroprotectants” (see as well as many other research articles published in scientific journals.

Dr. Donald Abrahms, chief of Hematology and Oncology from the University of California at San Francisco, has been researching CBD health benefits for many years and more research is available via the following YouTube link:

Aside from Dr Abrahms work, research by the US Government and other top US University Medical Research departments have shown CBD to carry significant benefits. CBD has shown positive as described in the United States Health Department Patent # 6,630,507 results with Parkinson’s disease, HIV, Down’s Syndrome, Crohn’s disease, Rheumatoid Arthritis, Diabetes, Post Heart Operation and Heart patients, including high blood pressure, Alzheimer’s and many other conditions. CBD has been shown to be a natural T-cell enhancer.

Three products are currently available from Medical Marijuana Inc’s enhanced drinking water beverage line:

CBD-infused water, which has all of the medical benefits of CBD.
CBD water, which has all of the additional 500 plus natural benefits less THC.
Hemp water, which uses all the direct benefits of hemp extracts.

Medical Marijuana Inc has several additional beneficial beverage lines which will be launched over the next several months.


Our mission is to be the world’s premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate, invest in and purchase value-added sustainable companies, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, pay homage to the visionaries and activists of the past and present, provide the platform from which the industry can emerge into a global sustainable economy for all. Medical Marijuana Inc recognizes the vast and unequaled opportunities that exist in the rapidly expanding hemp and medical marijuana industries. The scientific recognition of cannabis has brought legalized marijuana use to the forefront of mainstream discussion, thus opening the door for safe and lucrative investment opportunities.


CannaBANK’s mission is to help create a sustainable economy which in turn helps create a sustainable planet offering health and economic freedom through education and awareness.

CannaBANK™ and the CannaBANK™ logo are registered trademarks of Hemp Deposit & Distribution Corp. (HDDC), d/b/a CannaBANK, Inc. in the U.S. and certain other countries. All other trademarks mentioned in this document are the property of their respective owners. The use of the word “partner” does not imply a partner relationship between CannaBANK and any other company.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.